| .OH | Hydroxyl Radicals |
| 1,3BPG | 1,3 bisphosphoglycerate |
| Acetic acid | AcOH |
| ADMET | Absorption, distribution, metabolism, excretion, toxicity |
| Ag85 | Antigen 85 |
| AHLs | N-acyl homoserine lactones |
| AIs | Auto-inducers |
| ALFs | Shrimp antilipopolysaccharide factors |
| Aluminium chloride | AlCl |
| AmB | Amphotericin B |
| AMP | Antimicrobial peptides |
| AMR | antimicrobial resistance |
| API | Active pharmaceutical ingredient |
| ASPs | Antimicrobial Stewardship Plans |
| ATP-ABC | Adenosine triphosphate-Binding Cassette |
| AZT | Zidovudine |
| BBr3 | Boron tribromide |
| BGC | Biosynthetic gene cluster |
| BioA | 7,8- diaminopelargonic acid synthase |
| BnBr | Benzyl bromide |
| C2H5I | Ethyl iodide |
| C3Ds | Cephalosporin-3′-diazeniumdiolates |
| C6H6 | Benzene |
| CABP | Community-acquired bacterial pneumonia |
| CBD | Cannabidiol |
| CBG | Cannabigerol |
| CDI | Carbonyldiimidazole |
| CEO | Cinnamon essential oil |
| CFDC | Cefiderocol |
| CH2Cl2 | Dichloromethane |
| CH3CN | Acetonitrile |
| CoAF | Cobalt nanoferrite |
| CPPs | Cell-penetrating peptides |
| CPPs | Critical process parameters |
| CQAs | Critical quality attributes |
| CR | Carbapenem resistant |
| CRAB | Carbapenem-resistant Acinetobacter baumannii |
| CRE | Carbapenem-resistant Enterobacterales |
| Cu | Copper |
| CuAF | copper nanoferrite |
| CZA | Contezolid acefosamil |
| CZD | Contezolid |
| DABCO | Triethylenediamine |
| DAR | Darobactins |
| DBOs | Diazabicyclooctanones |
| DBU | 1,8-Diazabicyclo [5.4.0]undec-7-ene |
| DBU | 1,8-Diazabicyclo(5.4.0)undec-7-ene |
| DCM | Dichloromethane |
| Ddl | D-alanyl-D-alanine synthetase |
| Ddl-B | D-alanine-D-alanine ligase |
| Ddn | Deazaflavin-dependent nitroreductase |
| DDQ | 2,3-Dichloro-5,6-dicyano-1,4-bezoquinone |
| DIPEA | N,N-Diisopropylethylamine |
| DMAP | 4-Dimethylaminopyridine |
| DMC | Dimethyl carbonate |
| DMF | Dimethylformamide |
| DMSO | Dimethyl sulfoxide |
| DPD | (S)-4,5-dihydroxypentane-2,3-dione |
| DprE1 | Decaprenylphosphoryl-β-D-ribose 2′-epimerase |
| DS | Design space |
| DSF | Differential Scanning Fluorimetry |
| DSPG | Di-stearoyl-phosphatidylglycerol |
| E4P | D-erythrose-4-phosphate |
| E4PDH | Erythrose-4-phosphate dehydrogenase |
| ECC | Enterobacter cloacae complex |
| EOCM | Essential oil from Centipeda minima |
| EOOG | Egg oil-organogel |
| EOs | Plant essential oils |
| ESKAPE | Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species pathogens |
| Et3N | Triethylamine |
| EthR | Transcriptional repressor |
| EtOH | Ethanol |
| FBDD | Fragment-based drug design |
| FECL2 | Iron(II) chloride |
| FePPOPHydantoin | Porphyrin iron-based porous organic polymer |
| Fts-Z | Filamenting temperature-sensitive mutant Z |
| G3P | Glyceraldehyde-3-phosphate |
| GA | Glycyrrhizin |
| GC-MS | Gas chromatography-mass spectrometry |
| GRA | 18β-glycyrrhetinic acid |
| Gyr-B | DNA gyrase B subunits |
| H2CBD | 8,9-dihydrocannabidiol |
| HAM | Hamamelitannin |
| HCl | Hydrochloric acid |
| HGT | Horizontal gene transfer |
| HTS | High throughput screening |
| I2 | Iodine |
| InhA | 2-trans-enoyl-acyl carrier protein reductase |
| i-Pr2Net | N,N-Diisopropylethylamine |
| K2CO3 | Potassium carbonate |
| KI | Potassium iodide |
| KNCS | Potassium thiocyanate |
| KOH | Potassium hydroxide |
| Lf | Lactoferrin |
| LiOH | Lithium hydroxide |
| MATE | Multidrug and Toxic Compound Extrusion |
| MBC | Minimum bactericidal concentration |
| m-CPBA | meta-Chloroperoxybenzoic acid |
| MD | Molecular dynamics |
| MDR | Multidrug resistance |
| MEI | Iodomethane |
| MeOH, | Methanol |
| MIC | Minimum inhibitory concentration |
| MMC | Mitomycin C |
| MRSA | Methicillin-resistant S. aureus |
| Ms | Saturation magnetization |
| MSSA | Methicillin-sensitive Staphylococcus aureus |
| mtk-QSBER | multitasking model for quantitative-structure biological effect relationships |
| NaBH4 | Sodium borohydride |
| NaBH4 | Sodium borohydride |
| NaH | Sodium hydride |
| NaHCO3 | Sodium bicarbonate |
| NAOCH3 | Sodium methoxide |
| NAOH | Sodium hydroxide |
| NBS | N-Bromosuccinimide |
| n-Bu3SnH. | Tributyltin hydride |
| n-BuLi | n-Butllithium |
| NCS | N-Chlorosuccinimide |
| NIR | Near-infrared |
| NMR | Nuclear magnetic resonance |
| NO | Nitric oxide |
| NPET | Nascent peptide exit tunnel |
| NPs | Nanoparticles |
| NRPSs | non-ribosomal peptide synthetases |
| ODLs | Odilorhabdins |
| PABA | p-aminobenzoic acid |
| PACE | Proteobacterial Antimicrobial Compound Efflux |
| PBPs | Penicillin-binding proteins |
| PDA@FeS NPs | ferrous sulfide-polydopamine nanoparticles |
| Pd-C | Palladium on carbon |
| PE | Phosphatidyl-ethanolamine |
| PEITC | Phenethyl isothiocyanate |
| PGLEO | Psidium guajava (guava) leaf essential oil |
| PIPD1 | Piperidinol-containing molecule |
| PJI | Prosthetic joint infection |
| PKSs | Polyketide synthases |
| POCl3 | Phosphoryl chloride |
| PPA | Polyphosphoric acid |
| PTC | Peptidyl transferase center |
| QbD | Quality by design |
| QS | Quorum Sensing |
| RA | Risk Assessment |
| RIF-BSA-NPs | Rifampicin-loaded bovine serum albumin nanoparticles |
| RNAP | RNA polymerase |
| RND | Resistance Nodulation Division |
| ROS | Reactive oxygen species |
| ROS | Reactive oxygen species () |
| rt. | Room temperature |
| SAM (RaS) | Radical S-adenosylmethionine |
| SAR | Structure-activity relationships |
| Silver oxide | Ag2O |
| SMR | Small Multidrug Resistance |
| SSD | Silver Sulphadiazine |
| TB | Tuberculosis |
| TBAB | Tetra-n- butylammonium bromide |
| T-BUOH | Tert-Butyl alcohol |
| T-BUOK | Potassium tert-butoxide |
| TCA | Tricarboxylic acid cycle |
| Tf | Transferrin |
| THBTP | Tetrahydro-1-benzothiophene |
| THC | Trans-Δ-9-tetrahydrocannabinol |
| THF | Tetrahydrofuran |
| ThyX | Thymidylate synthase |
| TLM | Thiolactomycin |
| TPP | Target product profile |
| TQ | Thymoquinone |
| TriBE inhibitor | Pyrimidoindole inhibitor |
| TRPPs | Tetracycline ribosomal protection proteins |
| WHO | World Health Organization |
| XDR | extensively drug resistant |
| β-MGP | β-D-galactopyranoside |